Dose Escalation Study of Sanaria's Irradiated Sporozoite Vaccine (PFSPZ Vaccine), Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of PfSPZ Vaccine in Malaria-Experienced Adults in Burkina Faso.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary) ; Artesunate
- Indications Falciparum malaria
- Focus Adverse reactions
- 20 Jul 2017 Planned End Date changed from 3 Oct 2017 to 20 Apr 2019.
- 20 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 20 Apr 2019.
- 20 Jul 2017 Status changed from recruiting to active, no longer recruiting.